GE Aerospace's Q1 2026 reveals a booming business where the absolute biggest crisis is literally having too many aircraft to service.

In this episode:

• Why airlines panic-buying jets drove an 87% order surge

• The 70% backlog spike in delayed spare engine parts

• Margin erosion caused by an influx of new engine deliveries

• Why management capped full-year guidance over geopolitical conflict

• A new flight-test crack in the GE9X Boeing 777X engine

Wall Street punished the stock despite a massive revenue beat because the profit margins on brand new equipment just don't match the highly lucrative aftermarket services. The core debate now shifts from demand generation to pure physical execution as GE attempts to unclog a suffocating global supply chain while hedging against regional shocks.

GE Aerospace (GE) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Nano-X Imaging's Q4 2025 was a stark reality check, anchored by a massive $17.5 million impairment charge that highlights the painful gap between medical hardware ambition and actual commercial scale.

In ~10 minutes:

• Why management finally pulled the plug on their South Korean chip fab

• How the Vaso Health IT acquisition bought instant software revenue

• The bureaucratic bottlenecks pushing the hardware ramp to late 2026

• Why the market handed the stock a brutal 24% gap-down 📉

While teleradiology revenues flatlined at $3.1M, the decision to outsource semiconductor manufacturing to Switzerland stops the bleeding from a misguided COVID-era factory build. But with hospital installations still crawling, investors are being asked to endure another painful waiting game to see if the promised deployment momentum arrives.

Nano-X Imaging (NNOX) | Q4 FY2025

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Cleveland-Cliffs bounced back in Q1 2026, dodging a massive weather-driven cost spike while quietly winning major automakers back from the aluminum EV dream.

In ~10 minutes:

• Why automakers are retreating from aluminum to use high-strength steel.

• How an $80 million winter storm wrecked their un-hedged gas margins.

• Why the Canadian spot market is trading at a bizarre 40% discount.

• The absolute limit of Excel: upgrading mill sequencing to real-time AI.

Lourenco Goncalves is steering Cleveland-Cliffs through an incredibly noisy quarter. From freak storms masking a $95M EBITDA recovery to the realization that automakers can run advanced steel straight through their new aluminum stamping lines, the heavy industry giant is proving its resilience. Now, with cash flows set to pivot sharply into the green for Q2, management just needs geopolitics and un-hedged diesel to stay quiet.

Cleveland-Cliffs Inc. (CLF) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Ericsson's Q1 2026 earnings reveal a harsh paradox: while management brilliantly defended a 47.2% gross margin through supply chain judo, they are being actively squeezed by the very AI supercycle enriching the rest of the tech sector.

In ~10 minutes:

• Why the surging AI chip market is a hidden tax on telecom hardware.

• How 5G is pivoting to drone-detection and naval military contracts.

• The brutal SEK 3.8B restructuring charge that crushed EBIT.

• An unusual SEK 0.5B expense triggered by their own rising stock price.

Despite soft North American sales and massive currency headwinds, Ericsson kept its core economics intact by shifting volumes to India and Japan. However, the path through the rest of the year looks grueling as management races to outpace rising semiconductor costs with incoming restructuring savings. The market sent the stock down over 7% as a clear demand for proof in the second half.

Ericsson (ERIC) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Alcoa’s Q1 FY2026 was a split-screen quarter: stronger aluminum pricing lifted profit, while alumina weakness and working-capital timing crushed cash flow.

In this episode:

- Aluminum EBITDA jumped as realized prices rose, costs held.

- Alumina EBITDA turned negative on lower shipments and pricing.

- Free cash flow fell to -$298M on timing-heavy working capital.

- Inventory repositioning deferred EBITDA on 30,000 tons into Q2.

- San Ciprián restarted, but the refinery still burns cash.

We break down why revenue fell 7% even as profit improved, how Ma’aden and FX helped below the line, and why shares still slipped about 3% after hours. Then we look at Q2: better aluminum shipments and pricing support, but higher Section 232 tariffs, tax expense, and diesel costs keep the setup messy.

Company: Alcoa Corporation (AA) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Netflix's Q1 FY2026 was a real operating improvement wrapped inside a one-time $2.8B Warner termination fee, which is why the numbers looked great and the stock still sold off.

In this episode:

- Revenue rose to $12.25B, but UCAN slipped sequentially

- Operating margin hit 32.3% as costs and marketing fell

- Roughly three quarters of pretax improvement came below the line

- Japan led member growth after the World Baseball Classic spike

- Ads tier drove 60%+ of sign-ups in ads markets

NFLX still guided Q2 to $12.574B of revenue and a 32.6% operating margin, yet the stock fell roughly 10% after hours as EPS resets from $1.23 to a cleaner $0.78 without the breakup fee. We unpack why international did the heavy lifting, why cash was "more elevated than normal," and why Netflix's ad business is starting to look more like infrastructure than an experiment.

Company: Netflix, Inc. (NFLX) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Abbott Laboratories posted decent Q1 2026 numbers, but a massive $21 billion cancer-testing acquisition has Wall Street spooked by immediate EPS dilution and muddy comparability metrics.

In ~10 minutes:

• Why 3-to-9 month colonoscopy wait times justify the Exact Sciences buyout.

• Abbott’s rare corporate decision to cut adult nutrition prices to revive volume.

• Supply chain war rooms buffering local inventory to bypass Middle East shipping.

• The exact accounting shift that instantly blurred legacy growth numbers.

Abbott’s medical device core, anchored by a 13.2% growth rate, remains an absolute machine. Yet the decision to embed Exact Sciences immediately into "comparable sales" left analysts questioning whether it masks a softening organic diagnostic base, prompting a nearly 5% earnings-day drop. 📉 We unpack the financial optics versus the strategic reality of buying healthcare plumbing.

Company: Abbott Laboratories (ABT) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

In Q1 2026, TSMC's shift into manufacturing hardware for "Agentic AI" triggered a historic capital expenditure run rate, alongside stark warnings about the permanent structural costs of global expansion.

In ~10 minutes:

• High Performance Computing absorbs 61% of total wafer revenue.

• Agentic AI forces capital expenditure guidance to a $56B limit.

• CEO shuts down fast-track rumors: new mega-fabs take 5 years.

• Overseas footprint locks in a permanent 3-4% gross margin dilution.

• Geopolitics inflate the procurement costs of vital specialty gases.

Investors initially panicked, sending shares tumbling to $362 in the pre-market over margin anxiety before prices leveled out. Despite the impending structural drag of Western manufacturing sites, severe internal cost controls and the unbending physics of chipmaking keep TSMC entrenched at the apex of the semiconductor food chain. 📉

Company: Taiwan Semiconductor Manufacturing Company Limited (TSM) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

Despite a double-digit drop in system sales, ASML’s Q1 2026 gross margins surged to 53% as highly lucrative software upgrades rescued the quarter's profitability.

In ~10 minutes:

• How PEP software patches physically push EUV throughput to 230 WpH.

• The massive €13B operating cash flow swing and working capital drag.

• Firing lasers at supersonic tin to break the 1,000-watt light barrier.

• Why the newly raised €36B–€40B outlook completely shrugs off export bans.

The semiconductor supply chain is hitting severe bottlenecks downstream, with memory makers reportedly sold out through 2026. ASML finds itself uniquely insulated by unprecedented AI demand, leveraging physics breakthroughs like High-NA to compress 100 fabrication steps down to just 10. We unpack why the market missed the mark with its initial pre-market selloff, and why pricing power ultimately outweighs geopolitical turbulence 🛠️.

ASML Holding N.V. (ASML) | Q1 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.

CarMax essentially abandoned its long-held margin protections in Q4, intentionally slashing vehicle prices to revive stalled sales volume while quietly taking on riskier consumer debt.

In ~10 minutes:

• How the new CEO is applying hotel strategies to used cars

• The algorithmic math behind their surgical $1,000 price drops

• Why sub-prime auto loan penetration doubled in twelve months

• The liquidity red flag behind abruptly paused share buybacks

Wall Street punished the margin sacrifice, sending shares tumbling 15% following the report. While the aggressive discounting successfully bought back foot traffic, CarMax is effectively subsidizing that growth with its own balance sheet. With half the lot now stocked with older, high-mileage “Value Max” inventory and margins expected to squeeze further next quarter, management faces a delicate tightrope walk to reclaim market share 📉.

CarMax (KMX) | Q4 FY2026

AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.